Search research articles
Contact Us
Filters
Showing results (301-310 of 509) with videos related to
Page
of 51
Sort By:
Gynecologic Oncology
|
November 23, 2019
Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis
Cécile Le Page, Kurosh Rahimi, Manuel Rodrigues, et al.
Cancer Research
|
June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Gynecologic Oncology
|
September 15, 2021
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL)
Stephanie Gaillard, Ana Oaknin, Isabelle Ray-Coquard, et al.
Breast Cancer (Dove Medical Press)
|
May 4, 2023
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
Benoîte Mery, Christine Ménétrier-Caux, Laure Montané, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 5, 2025
Best original research presented at the 26th European Congress on Gynaecological Oncology: Best of ESGO 2025
Houssein El Hajj, Joanna Kacperczyk-Bartnik, Nicolò Bizzarri, et al.
Acta Neuropathologica
|
January 5, 2018
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration
Mathilde Small, Isabelle Treilleux, Coline Couillault, et al.
The Lancet. Oncology
|
February 15, 2015
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial
Axel Le Cesne, Jean-Yves Blay, Julien Domont, et al.
JAMA Oncology
|
July 25, 2024
Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure: A Nonrandomized Controlled Trial
Michael Birrer, Guiling Li, Mayu Yunokawa, et al.
Oncology Letters
|
March 22, 2016
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study
Frédéric Selle, George Emile, Patricia Pautier, et al.
Annals of Surgical Oncology
|
January 29, 2020
Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study
Mathias Neron, Christophe Sajous, Simon Thezenas, et al.
Page
of 51
Search research articles
Search
Showing results (301-310 of 509) with videos related to
Sort By:
Page
of 51
Gynecologic Oncology
|
November 23, 2019
Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis
Cécile Le Page, Kurosh Rahimi, Manuel Rodrigues, et al.
Cancer Research
|
June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Gynecologic Oncology
|
September 15, 2021
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL)
Stephanie Gaillard, Ana Oaknin, Isabelle Ray-Coquard, et al.
Breast Cancer (Dove Medical Press)
|
May 4, 2023
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
Benoîte Mery, Christine Ménétrier-Caux, Laure Montané, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 5, 2025
Best original research presented at the 26th European Congress on Gynaecological Oncology: Best of ESGO 2025
Houssein El Hajj, Joanna Kacperczyk-Bartnik, Nicolò Bizzarri, et al.
Acta Neuropathologica
|
January 5, 2018
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration
Mathilde Small, Isabelle Treilleux, Coline Couillault, et al.
The Lancet. Oncology
|
February 15, 2015
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial
Axel Le Cesne, Jean-Yves Blay, Julien Domont, et al.
JAMA Oncology
|
July 25, 2024
Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure: A Nonrandomized Controlled Trial
Michael Birrer, Guiling Li, Mayu Yunokawa, et al.
Oncology Letters
|
March 22, 2016
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study
Frédéric Selle, George Emile, Patricia Pautier, et al.
Annals of Surgical Oncology
|
January 29, 2020
Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study
Mathias Neron, Christophe Sajous, Simon Thezenas, et al.
Page
of 51